Gut Bacteria Byproduct May Raise Heart Failure Risk

Cleveland Clinic study finds that elevated blood TMAO levels may also be linked to worse long-term prognosis for heart failure patients

By
estaff
-
Published:
0
Cleveland Clinic researchers are learning more about a chemical byproduct of intestinal bacteria-dependent digestion. The chemical trimethylamine N-oxide (TMAO) was found to contribute to heart disease and be a predictor of future heart attacks and strokes.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

RELATED ARTICLESMORE FROM AUTHOR